BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10348681)

  • 21. Latent reservoirs of HIV infection: flushing with IL-2?
    Cooper DA; Emery S
    Nat Med; 1999 Jun; 5(6):611-2. PubMed ID: 10371491
    [No Abstract]   [Full Text] [Related]  

  • 22. A new latent HIV reservoir.
    Koup RA
    Nat Med; 2001 Apr; 7(4):404-5. PubMed ID: 11283657
    [No Abstract]   [Full Text] [Related]  

  • 23. The emerging race to cure HIV infections.
    Cohen J
    Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of infection caused by human immunodeficiency virus in the Russian Federation].
    Kravchenko AV; Iurin OG; Beliaeva VV; PokrovskiÄ­ VV
    Ter Arkh; 2009; 81(4):64-9. PubMed ID: 19514425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 dynamics in vivo: implications for therapy.
    Simon V; Ho DD
    Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
    J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
    Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
    Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion.
    Daar ES; Bai J; Hausner MA; Majchrowicz M; Tamaddon M; Giorgi JV
    Ann Intern Med; 1998 May; 128(10):827-9. PubMed ID: 9599194
    [No Abstract]   [Full Text] [Related]  

  • 30. Valproic acid: a potential role in treating latent HIV infection.
    Routy JP
    Lancet; 2005 Aug 13-19; 366(9485):523-4. PubMed ID: 16099272
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immune control of HIV-infection and replication].
    Matsushita S
    Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV infection: how effective is drug combination treatment?
    Grossman Z; Feinberg M; Kuznetsov V; Dimitrov D; Paul W
    Immunol Today; 1998 Nov; 19(11):528-32. PubMed ID: 9818549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stubborn AIDS reservoirs vulnerable to new treatments.
    Cohen J
    Science; 1997 May; 276(5314):898-9. PubMed ID: 9163035
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute primary HIV infection.
    Quinn TC
    JAMA; 1997 Jul; 278(1):58-62. PubMed ID: 9207340
    [No Abstract]   [Full Text] [Related]  

  • 35. Costs versus benefits: best possible and best practical treatment regimens for HIV.
    Krakovska O; Wahl LM
    J Math Biol; 2007 Mar; 54(3):385-406. PubMed ID: 17205357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can HIV be cured?
    Stevenson M
    Sci Am; 2008 Nov; 299(5):78-83. PubMed ID: 18998350
    [No Abstract]   [Full Text] [Related]  

  • 37. Getting to the HAART of T cell dynamics.
    Roederer M
    Nat Med; 1998 Feb; 4(2):145-6. PubMed ID: 9461179
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between antiretroviral drug plasma concentrations and viral load in children.
    Treluyer JM; Burgard M; Cazali N; Quartier P; Veber F; Rey E; Alkaer G; Rouzioux C; Pons G; Blanche S
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):112-5. PubMed ID: 12514422
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Dialer I; Seybold U; Bogner J
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():33-5. PubMed ID: 26048118
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapeutic interventions targeting HIV interactions with host-associated carbohydrates.
    McReynolds KD; Gervay-Hague J
    Chem Rev; 2007 May; 107(5):1533-52. PubMed ID: 17439183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.